A Very Successful 2018 at Nanoview Biosciences

2018 has been a wonderful year for our company and we highlight below the most important milestones.

Jerry Williamson appointed Chief Executive Officer - July 2018

"The markets for exosome detection and characterization are exploding and NanoView has the opportunity to rapidly emerge as a leading

technology provider for basic research and therapeutic and diagnostic development."  Exciting words from Jerry Williamson who took the helm as CEO of Nanoview on July 1st. Mr Williamson has worked in life sciences arena for more than 30 years, a key player within companies specialising in such fields as genomic profiling and molecular diagnostics. His corporate roles have been primarily in business development and commercial operations. He succeeded Dr David Freedman, one of Nanoview's co-founders. 

Grant awarded from the National Science Foundation - September 2018

The National Science Foundation (SBIR), the agency that supports fundamental research and education across all fields of science and engineering awarded Nanoview Biosciences a Phase II grant of $750,000. With the aim of solving the problems that current research methods have trying to effectively identify and characterise exosomes, the funds will be used to further enhance the completed Phase I research and development of our innovative ExoView™ system, advancing the platform and preparing for its commercialization. 

NanoView Completes $10 Million Series B Financing - October 2018

The list of investors participating in the final round of Series B funding was strengthened in October.  Northpond Ventures,  impressed with our progress and recognizing the immense opportunity our platform technology has for the life sciences field, joined existing financiers, among them, PBM Capital Group and Sands Capital Ventures, putting Nanoview in a position to complete the first applications of the ExoView™ system. 

We regularly update our website with news and details of events we are attending. Alternatively, you can follow us via our Twitter account: https://twitter.com/nanoviewbio

NanoView Biosciences